Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict painful skin rash in hospital patients

NCT ID NCT06978751

Knowledge-focused Sponsor: Örebro University, Sweden Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 271 hospital patients with incontinence to find out which factors most strongly predict a common skin problem called incontinence-associated dermatitis (IAD). Researchers tracked things like age, stool consistency, and mobility, checking patients' skin daily. The goal is to create a risk assessment tool that helps nurses prevent IAD before it starts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple tool that helps nurses predict and prevent painful skin rashes in incontinent patients.
What could go wrong
This is an observational study, not a treatment trial. The tool may not be accurate enough for all hospital settings or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

271 people

The number who actually took part.

Started

May 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult hospitalised patients with urinary, faecal, or double incontinence who are free of IAD at inclusion.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient or their legally authorized representative signed informed consent. * The patient is aged 18 years or older. * The patient suffers from incontinence\* (urinary, faecal, double incontinence). * The patient is free of IAD at inclusion. \*Incontinence is defined as involuntary loss of urine and/or stool. Exclusion Criteria: * Patients admitted to emergency departments, paediatric units, maternity units, psychiatric units, and palliative care units. * Patients who are receiving end-of-life care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incontinence-associated dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dermatitis Fecal Incontinence Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Incontinence-associated dermatitis

Contacts and locations

Locations

  • AZ Delta

    Rumbeke, Belgium

  • AZ Groeninge

    Kortrijk, Belgium

  • AZ Sint-Lucas

    Ghent, Belgium

  • AZ West

    Veurne, Belgium

  • Sint-Jozefskliniek

    Izegem, Belgium

  • University Hospital Ghent

    Ghent, Belgium

  • Uppsala University Hospital

    Uppsala, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.